Keyphrases
Antithrombin Activity
25%
Arterialization
37%
Arterialized
25%
Associated Matrix
12%
Canine Model
12%
Carotid Artery
12%
Control Matrix
12%
Extracellular Signal-regulated Kinase
12%
Extracellular Signal-regulated Kinase 1/2
100%
Factor Level
12%
Inflammatory Activity
12%
Inflammatory Mediators
100%
Interposition Graft
12%
Jugular Vein
12%
Local Inflammatory Response
12%
Matrix Metalloproteinase Inhibitors
12%
Matrix metalloproteinase-2 (MMP-2)
62%
Matrix metalloproteinase-9 (MMP-9)
37%
Matrix Metalloproteinases
100%
MEK1
12%
Membrane Types
50%
Mitogen-activated Protein Kinase
12%
MMP Expression
12%
MT1-MMP
12%
Myeloperoxidase Activity
25%
Neutrophil Infiltration
25%
Pathway Control
12%
Polymorphonuclear Neutrophils
25%
Smooth muscle Cells
12%
Thrombin
37%
TIMP-2
50%
Tumor Necrosis Factor-α
37%
UO126
12%
Vascular Remodeling
12%
Vein Graft
100%
Medicine and Dentistry
Carotid Artery
12%
Contralateral
12%
Downregulation
12%
Gelatinase A
50%
Gelatinase B
37%
Inflammatory Mediator
100%
Jugular Vein
12%
Matrix Metalloproteinase
100%
Matrix Metalloproteinase 14
12%
Matrix Metalloproteinase 15
12%
Mitogen Activated Protein Kinase 3
100%
Mitogen Activated Protein Kinase Kinase
12%
Mitogen-Activated Protein Kinase
12%
Myeloperoxidase
25%
Neutrophil Chemotaxis
25%
Serositis
12%
Smooth Muscle Cell
12%
Thrombin
62%
Tissue Inhibitor of Metalloproteinase 2
50%
Tumor Necrosis Factor
37%
U0126
12%
Upregulation
37%
Vascular Remodeling
12%
Vein Graft
100%
Neuroscience
Extracellular Signal-Regulated Kinases
100%
Matrix Metalloproteinase
100%
Matrix Metalloproteinase 14
16%
Matrix Metalloproteinase 15
16%
Metalloprotease Inhibitor
66%
Mitogen-Activated Protein Kinase Kinase
16%
MMP2
66%
MMP9
50%
Myeloperoxidase
33%
Necrosis
50%
Neutrophil Chemotaxis
33%
Neutrophil Granulocyte
33%
Thrombin
83%